Doloproct

Doloproct is a rectal medication combining fluocortolone pivalate and lidocaine hydrochloride. It is commonly used for localized relief of pain and inflammation. This product is manufactured by Karo Pharma AB in the EU.

Doloproct is typically used for the relief of pain and inflammation in the rectal area. The active ingredients, fluocortolone pivalate and lidocaine hydrochloride, work together to provide localized relief. This medication is often recommended for conditions that cause discomfort in the rectal region, such as hemorrhoids or anal fissures.

When applied as directed, Doloproct may help reduce pain and inflammation in the rectal area. Users may experience a soothing effect due to the combination of a corticosteroid and a local anesthetic. The effects are generally localized to the application site.

Doloproct should be used as directed by a healthcare professional. It is important to follow the recommended usage guidelines to avoid potential side effects. Prolonged use should be avoided unless advised by a healthcare provider. Always consult a healthcare professional before using this medication, especially if you have any underlying medical conditions.

Doloproct may interact with other medications, particularly those that affect the immune system or blood clotting. It is advisable to inform your healthcare provider about all medications you are taking before using Doloproct. Avoid using this medication with other rectal products unless directed by a healthcare professional.